Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

USA Knotless Surgical Sutures Market Snapshot (2023 to 2033)

According to Future Market Insights research, during the projected period, the USA knotless surgical sutures market is expected to grow at a CAGR of 3.6%. The market value is projected to increase from US$ 181.0 Million in 2023 to US$ 258.7 Million by 2033. The USA knotless surgical sutures was valued at US$ 175.7 Million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 3.1% in 2023.

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 175.7 Million
Market Value 2023 US$ 181.0 Million
Market Value 2033 US$ 258.7 Million
CAGR 2023 to 2033 3.6%
Share of Top 5 Companies 32.1%
Key Players The key players in the knotless surgical sutures market are Medtronic, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson (Ethicon), CONMED Corporation, Corza Medical, CP Medical, DemeTECH Corporation, Sutumed, DSI Dental Solution, Golnit Sutures, Vital Sutures, Atramat, Unilene, Advanced MedTech Solutions Pvt. Ltd, Dolphin Sutures, Arthrex, Inc, GMD Group, Dynek Pvt Ltd, Kono Seisakusho Co.,Ltd ), Olimp- Surgical Sutures, Lotus Surgicals, Unisur Lifecare Pvt Ltd.

The knotless barbed suture is a monofilament suture specifically designed with barbs. It is a new kind of suture designed for use in both skin and deeper structures. The suture is orientated in the opposite direction to the needle. Post-injury, knotless sutures hold tissues together and enhance the natural process of healing. They are commonly used on the skin, internal tissues, organs and blood vessels.

Overall, the technological advancements in sutures is likely to boost the market in the coming years.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of USA Knotless Surgical Sutures Market from 2015 to 2022 Vs Market Outlook for 2023 to 2033

Sales of the knotless surgical sutures market in the USA grew at a CAGR of 2.3% from 2015 to 2022. The USA knotless surgical sutures market contributes around 37.7% revenue share to the global knotless surgical sutures market in 2022, which was valued at US$ 465.6 Million.

The surgical suture industry has seen some significant advances in technology in recent years. The use of synthetic materials with outstanding tissue-holding capabilities and lower risk of infection and scarring, suture coatings, braiding technologies, barbed sutures, and novel specialised sutures that are in development are some of the breakthroughs in surgical sutures.

Triclosan-coated polyglactin 910 (Vicryl Plus Antibacterial: Ethicon) has been reported to reduce the prevalence of surgical site infections by 30%. These sutures were discovered to have similar handling and tension forces to those of common suture materials. Despite being relatively non-toxic, triclosan has been known to cause skin rashes and allergic reactions.

  • The largest range of antibacterial sutures in the world was introduced by Dolphin Sutures on July 13, 2022. The R&D team coordinated at Dolphin Sutures and worked hard to create a broad range of antibacterial sutures with a focus on patient safety and giving surgeons confidence in a variety of clinical environments.Considering this, FMI expects the USA knotless surgical sutures market to grow at a CAGR of 3.6% through the forecasted years.

What are the Key Opportunities in the USA Knotless Surgical Sutures Market?

The increasing aging population and rising incidence of traffic accidents, trauma, burns, cosmetic, orthopedic, cardiovascular, and other surgical procedures offer significant market potential for surgical sutures.

  • Road traffic crashes, which are the leading cause of injury deaths and the 10th leading cause of all deaths worldwide, now account for a surprising proportion of the USA burden of disease. An estimated 1.2 million people are killed in road traffic crashes each year, and more than 50 million are injured, occupying 30 to 70 percent of hospital beds in non-industrialized countries.

Accidents can result in significant tissue damage, requiring reconstructive surgeries to restore the affected area's form and function. Knotless surgical sutures play a role in reconstructive procedures by providing precise and secure wound closure, which is essential for successful outcomes. The rise in accident cases can lead to an increased demand for reconstructive surgeries, indirectly driving the demand for knotless surgical sutures.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors Could Possibly Restrain the Growth of the USA Knotless Surgical Sutures Market?

The market for surgical sutures is anticipated to see certain growth restraints due to the rising adoption of substitute wound closure techniques including skin adhesives and tissue sealants. Manufacturers in the USA market for knotless surgical sutures compete with domestic and international businesses across all of their product lines.

When compared to suturing, a lengthy wound can be stapled in 25–50% less time. If used properly, staples can help reduce tissue stress. Staples are very strong and are excellent for closing wounds that are under significant tension. Staples are also generally painless to remove and offer great wound reversal.

The development of surgical adhesives and sealants has provided an alternative method of wound closure in certain surgical procedures. These products can be used in place of traditional sutures, including knotless surgical sutures, to achieve wound closure. The use of surgical adhesives and sealants may reduce the demand for knotless sutures in specific surgical applications.

Country-wise Insights

What Makes the Northeast USA the Dominating State in the Knotless Surgical Sutures Market?

The Northeast USA dominated the USA market with a value share of around 29.0% in 2022.

Northeast USA has a high healthcare expenditure, and patients are more willing to spend money on effective treatments for knotless surgical sutures. This trend is driving the growth of the market as more patients seek treatment options that can provide them with required care. The growing prevalence of number of accidents such as road accidents and trauma are driving the demand for surgical sutures in the Northeast state of USA and thereby, increase in the adoption of knotless surgical sutures.

What Makes Midwest an Emerging Market for Knotless Surgical Sutures?

Midwest is projected to be the most attractive market in knotless sutures growing at a CAGR of close to 4.1% over the forecast period.

In the United States, knotless surgical sutures are gaining popularity, especially in the Midwest, where there is an increasing need for quick and affordable surgical sutures. The market is anticipated to rise as Knotless Sutures become more widely used. The Midwest market is predicted to grow quickly as the use of technologies such human tendons and tough gel sutures, which have the potential to considerably boost operating efficiency, grows.

Such futuristic steps and missions are going to escalate Midwest’s knotless surgical sutures market in the projected period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Why Absorbable Surgical Sutures Is Largely an Adopted Product Option for Knotless Surgical Sutures?

The absorbable surgical sutures segment held the major chunk of 61.0% of the USA market by the end of 2022.

Absorbable sutures can break down naturally over the time, within the body itself. They eliminate the need for suture removal, which can be beneficial for patients and reduce the risk of complications associated with suture removal procedures.

Absorbable sutures are commonly used for internal tissues that heal relatively quickly or in areas that are difficult to access for suture removal.

Which Raw Material Is Mostly Adopted in the USA Knotless Surgical Sutures Market?

Polyglactin absorbable surgical sutures were the predominant segment with a market share of 22.4% in the USA market by the end of 2022.

Polyglactin sutures offer adequate tensile strength, allowing them to hold tissues together during the critical healing period. The sutures maintain their strength for a sufficient duration, providing support until the wound heals. Polyglactin sutures are biodegradable, meaning they break down into biocompatible byproducts that can be metabolized and eliminated by the body. This property eliminates the need for suture removal procedures.

As it is the mostly used raw material, it holds significant market share in the USA market.

By Source Which Segment Showed Significant Shares In The USA Market In 2022?

The synthetic source segment is accounted for a revenue share of 51.3% in the USA market at the end of 2022.

Synthetic knotless sutures often utilize innovative anchoring mechanisms or self-locking technology to secure the suture in place without the need for knots. These mechanisms can provide reliable and secure closure, minimizing the risk of suture slippage or failure.

  • In April 2021, Dolphin Sutures introduced the non-absorbable sutures made of Polytetrafluoroethylene in India. The product launch in India will help expand its dental product line for the first time.

Which Application Dominates the USA Market in 2022?

The cardiovascular procedures segment accounted for a revenue share of 32.2% in the USA market at the end of 2022.

In cardiac surgery, it is possible to close the right atrium cannulation site with knotless barbed sutures and an extra self-locking technique without any immediate or long-term consequences. This creates opportunities for minimally invasive heart surgery employing knotless barbed sutures. This work demonstrates that barbed knotless sutures effectively close a low-pressure heart structure, which could speed up minimally invasive surgery.

  • According to the Lifespan Health System, Heart disease is one of the prominent cause leading to death for men and women in the United States. In 2018, there were about 500,000 open heart surgeries performed each year.

Which End User Dominates the Global Market in 2022?

The hospital laboratories accounted for a revenue share of 34.9% in the USA market at the end of 2022.

Hospital laboratories plays a role in evaluating the performance and characteristics of various sutures, including knotless sutures, through testing and research. They might assess factors such as suture strength, biocompatibility, and tissue response. These evaluations can contribute to the understanding and selection of appropriate sutures for surgical procedures.

Competitive Landscape

Among the primary approaches used by organizations to get a competitive edge in the market are new launches, technical advancements, and regulatory compliance, acquisition and distribution agreements with other businesses to expand their business.

For instance:

  • The largest range of antimicrobial sutures in the world was introduced by Dolphin Sutures in July 2022. The project's main goals are to improve patient safety and give surgeons more assurance in a range of clinical situations.
  • According to a contract signed in July 2018, CP Medical will market and distribute B. Braun's veterinary infusion therapy product range as well as a few of its wound therapy products in the USA and Canada.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in USA knotless surgical sutures market space, which are available in the full report.

Scope of the Knotless Surgical Sutures Industry Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2015 to 2022
Market Analysis USD Million for Value
Key Country Covered USA
Key States Covered Northeast, Midwest, Southeast, Southwest, West
Key Segments Covered Product, Raw Material, Source, Application End User, and Region
Key Companies Profiled
  • Medtronic
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • Johnson & Johnson (Ethicon)
  • CONMED Corporation
  • Corza Medical
  • CP Medical
  • DemeTECH Corporation
  • Sutumed
  • DSI Dental Solution
  • Golnit Sutures
  • Vital Sutures
  • Atramat
  • Unilene
  • Advanced MedTech Solutions Pvt. Ltd
  • Dolphin Sutures
  • Arthrex, Inc
  • GMD Group
  • Dynek Pvt Ltd
  • Kono Seisakusho Co.,Ltd )
  • Olimp- Surgical Sutures
  • Lotus Surgicals
  • Unisur Lifecare Pvt Ltd.
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Key Segments Covered in Knotless Surgical Sutures Industry Research

By Product:

  • Absorbable Surgical Sutures
  • Non- Absorbable Surgical Sutures

By Raw Material:

  • Polyglycolic Acid Absorbable Surgical Suture
  • Polyglactin Absorbable Surgical Sutures
  • Catgut Absorbable Surgical Sutures
  • Poliglecaprone Absorbable Surgical Sutures
  • Polydioxanone Absorbable Surgical Sutures
  • Polypropylene Non-Absorbable Surgical Sutures
  • Nylon (poylamide) Non-Absorbable Surgical Sutures
  • Polyester Non-Absorbable Surgical Sutures
  • Polyvinylidene fluoride(PVDF) Non-Absorbable Surgical Sutures
  • Silk Non-Absorbable Surgical Sutures
  • Stainless Steel Non-Absorbable Surgical Sutures

By Source:

  • Natural
  • Synthetic
    • Monofilament
    • Braided
  • Coated
  • Uncoated

By Application:

  • Cardiovascular Procedures
  • General Surgery Procedures
  • Ophthalmic Procedures
  • Orthopedic Procedures
  • Dental Procedures
  • Gastroenterology Procedures
  • Gynecology Procedures
  • Plastic Surgery Procedures
  • Veterinary Procedures

By End User:

  • Hospital Laboratories
  • Specialized Clinics
  • Ambulatory Surgical Centers
  • Veterinary Hospitals
  • Veterinary Clinics

By Region:

  • Northeast
  • Midwest
  • Southeast
  • Southwest
  • West

Frequently Asked Questions

How much is the USA Knotless Surgical Sutures Market Worth?

The market is valued at US$ 181 million in 2023.

What is the Forecasted Growth Rate for the Market?

The Market is estimated to develop at a CAGR of 3.6%.

What is the Estimated Value of the Market in 2033?

The market is estimated to reach US$ 258.7 million by 2033.

What is the Expected Market Share of the Top 5 Companies?

The top 5 companies are expected to hold 32.1% of the market.

What are the Key Opportunities in the Market?

Healthcare spending, accident rates, and innovation are the key opportunities.

Table of Content

1. Executive Summary

    1.1. USA Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value-Added Insights

    4.1. Product Adoption / Usage Analysis

    4.2. Branding and Promotional Strategies

    4.3. Reimbursement Landscape

    4.4. Regulatory Scenario

    4.5. PESTLE Analysis

    4.6. Porter’s Analysis

5. Market Demand Analysis 2015 to 2022 and Forecast, 2023 to 2033

    5.1. Historical Market Volume (Units) Analysis, 2015 to 2022

    5.2. Current and Future Market Volume (Units) Projections, 2023 to 2033

        5.2.1. Y-o-Y Growth Trend Analysis

6. Market - Pricing Analysis

    6.1. Regional Pricing Analysis By Product

    6.2. Pricing Break-up

        6.2.1. Manufacturer-Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. USA Average Pricing Analysis Benchmark

    6.4. Pricing Assumptions

7. Market Demand (in Value or Size in US$ Million) Analysis 2015 to 2022 and Forecast, 2023 to 2033

    7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2022

    7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Macro-Economic Factors

        8.1.1. Gross Domestic Product by Region & Country,

        8.1.2. USA Per-Capita Healthcare Expenditure

    8.2. Forecast Factors - Relevance & Impact

        8.2.1. Historical Growth of Top Brands

        8.2.2. Rise in the number of surgeries

        8.2.3. Rising Demand in Emerging Economies

        8.2.4. Strategic Mergers and Acquisitions

        8.2.5. Local Player Growth

        8.2.6. Rise in Number of Amputation Surgeries

        8.2.7. Increase in Trauma cases

    8.3. Market Dynamics

        8.3.1. Drivers

        8.3.2. Restraints

        8.3.3. Opportunity Analysis

    8.4. Covid-19 Analysis

9. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Product

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2015 to 2022

    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        9.3.1. Absorbable Surgical Sutures

        9.3.2. Non-Absorbable Surgical Sutures

    9.4. Market Attractiveness Analysis By Product

10. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Raw Material

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Raw Material, 2015 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Raw Material, 2023 to 2033

        10.3.1. Polyglycolic Acid Absorbable Surgical Sutures

        10.3.2. Polyglactin Absorbable Surgical Sutures

        10.3.3. Catgut Absorbable Surgical Sutures

        10.3.4. Linen Absorbable Surgical Sutures

        10.3.5. Cotton Absorbable Surgical Sutures

        10.3.6. Nylon (poylamide) Non-Absorbable Surgical Sutures

        10.3.7. Polyester Non-Absorbable Surgical Sutures

        10.3.8. Polyvinylidene fluoride(PVDF) Non-Absorbable Surgical Sutures

        10.3.9. Silk Non-Absorbable Surgical Sutures

        10.3.10. Stainless Steel Non-Absorbable Surgical Sutures

    10.4. Market Attractiveness Analysis By Raw Material

11. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Source

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis By Source, 2015 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Source, 2023 to 2033

        11.3.1. Natural

        11.3.2. Synthetic

            11.3.2.1. Multifilament

            11.3.2.2. Braided

        11.3.3. Coated

        11.3.4. Uncoated

    11.4. Market Attractiveness Analysis By Source

12. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Application

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By Application, 2015 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        12.3.1. Cardiovascular Procedures

        12.3.2. General Surgery Procedures

        12.3.3. Ophthalmic Procedures

        12.3.4. Orthopedic Procedures

        12.3.5. Dental Procedures

        12.3.6. Gastroenterology Procedures

        12.3.7. Gynecology Procedures

        12.3.8. Plastic Surgery Procedures

        12.3.9. Veterinary Procedures

    12.4. Market Attractiveness Analysis, By Application

13. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by End User

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2022

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        13.3.1. Hospitals

        13.3.2. Clinics

        13.3.3. Ambulatory Surgical Centers

        13.3.4. Group Dental Practice

        13.3.5. Veterinary Hospitals

        13.3.6. Veterinary Clinics

    13.4. Market Attractiveness Analysis By End User

14. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Region

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2022

    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        14.3.1. Northeast USA

        14.3.2. Midwest USA

        14.3.3. Southeast USA

        14.3.4. Southwest USA

        14.3.5. East USA

    14.4. Market Attractiveness Analysis By Region

15. Northeast USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022

    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        15.3.1. By Product

        15.3.2. By Raw Material

        15.3.3. By Source

        15.3.4. By Application

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Product

        15.4.2. By Raw Material

        15.4.3. By Source

        15.4.4. By Application

        15.4.5. By End User

16. Midwest USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022

    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        16.3.1. By Product

        16.3.2. By Raw Material

        16.3.3. By Source

        16.3.4. By Application

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Product

        16.4.2. By Raw Material

        16.4.3. By Source

        16.4.4. By Application

        16.4.5. By End User

17. Southeast USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022

    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        17.3.1. By Product

        17.3.2. By Raw Material

        17.3.3. By Source

        17.3.4. By Application

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Product

        17.4.2. By Raw Material

        17.4.3. By Source

        17.4.4. By Application

        17.4.5. By End User

18. Southwest USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022

    18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        18.3.1. By Product

        18.3.2. By Raw Material

        18.3.3. By Source

        18.3.4. By Application

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Product

        18.4.2. By Raw Material

        18.4.3. By Source

        18.4.4. By Application

        18.4.5. By End User

19. West USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022

    19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033

        19.3.1. By Product

        19.3.2. By Raw Material

        19.3.3. By Source

        19.3.4. By Application

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Product

        19.4.2. By Raw Material

        19.4.3. By Source

        19.4.4. By Application

        19.4.5. By End User

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies (Surgical Sutures)

    20.2. Market Concentration

    20.3. Market Share Analysis of Top Players

        20.3.1. Regional Footprint of Players

        20.3.2. Product Footprint by Players

        20.3.3. Channel Footprint by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Key Development Analysis

    21.3. Competition Benchmarking

    21.4. Competition Deep Dive

        21.4.1. Medtronic Plc

            21.4.1.1. Overview

            21.4.1.2. Product Portfolio

            21.4.1.3. key Financials

            21.4.1.4. Sales Footprint

            21.4.1.5. Strategy Overview

                21.4.1.5.1. Marketing Strategy

                21.4.1.5.2. Product Strategy

                21.4.1.5.3. Channel Strategy

        21.4.2. B. Braun Melsungen AG

            21.4.2.1. Overview

            21.4.2.2. Product Portfolio

            21.4.2.3. key Financials

            21.4.2.4. Sales Footprint

            21.4.2.5. Strategy Overview

                21.4.2.5.1. Marketing Strategy

                21.4.2.5.2. Product Strategy

                21.4.2.5.3. Channel Strategy

        21.4.3. Teleflex Incorporated

            21.4.3.1. Overview

            21.4.3.2. Product Portfolio

            21.4.3.3. key Financials

            21.4.3.4. Sales Footprint

            21.4.3.5. Strategy Overview

                21.4.3.5.1. Marketing Strategy

                21.4.3.5.2. Product Strategy

                21.4.3.5.3. Channel Strategy

        21.4.4. Johnson & Johnson (Ethicon)

            21.4.4.1. Overview

            21.4.4.2. Product Portfolio

            21.4.4.3. key Financials

            21.4.4.4. Sales Footprint

            21.4.4.5. Strategy Overview

                21.4.4.5.1. Marketing Strategy

                21.4.4.5.2. Product Strategy

                21.4.4.5.3. Channel Strategy

        21.4.5. CONMED Corporation

            21.4.5.1. Overview

            21.4.5.2. Product Portfolio

            21.4.5.3. key Financials

            21.4.5.4. Sales Footprint

            21.4.5.5. Strategy Overview

                21.4.5.5.1. Marketing Strategy

                21.4.5.5.2. Product Strategy

                21.4.5.5.3. Channel Strategy

        21.4.6. Corza Medical

            21.4.6.1. Overview

            21.4.6.2. Product Portfolio

            21.4.6.3. key Financials

            21.4.6.4. Sales Footprint

            21.4.6.5. Strategy Overview

                21.4.6.5.1. Marketing Strategy

                21.4.6.5.2. Product Strategy

                21.4.6.5.3. Channel Strategy

        21.4.7. CP Medical

            21.4.7.1. Overview

            21.4.7.2. Product Portfolio

            21.4.7.3. key Financials

            21.4.7.4. Sales Footprint

            21.4.7.5. Strategy Overview

                21.4.7.5.1. Marketing Strategy

                21.4.7.5.2. Product Strategy

                21.4.7.5.3. Channel Strategy

        21.4.8. DemeTECH Corporation

            21.4.8.1. Overview

            21.4.8.2. Product Portfolio

            21.4.8.3. key Financials

            21.4.8.4. Sales Footprint

            21.4.8.5. Strategy Overview

                21.4.8.5.1. Marketing Strategy

                21.4.8.5.2. Product Strategy

                21.4.8.5.3. Channel Strategy

        21.4.9. Sutumed

            21.4.9.1. Overview

            21.4.9.2. Product Portfolio

            21.4.9.3. key Financials

            21.4.9.4. Sales Footprint

            21.4.9.5. Strategy Overview

                21.4.9.5.1. Marketing Strategy

                21.4.9.5.2. Product Strategy

                21.4.9.5.3. Channel Strategy

    21.5. 21.4.7. DSI Dental Solution

            21.5.1.1. Overview

            21.5.1.2. Product Portfolio

            21.5.1.3. key Financials

            21.5.1.4. Sales Footprint

            21.5.1.5. Strategy Overview

                21.5.1.5.1. Marketing Strategy

                21.5.1.5.2. Product Strategy

                21.5.1.5.3. Channel Strategy

    21.6. 21.4.8. Golnit Sutures

            21.6.1.1. Overview

            21.6.1.2. Product Portfolio

            21.6.1.3. key Financials

            21.6.1.4. Sales Footprint

            21.6.1.5. Strategy Overview

                21.6.1.5.1. Marketing Strategy

                21.6.1.5.2. Product Strategy

                21.6.1.5.3. Channel Strategy

        21.6.2. Vital Sutures

            21.6.2.1. Overview

            21.6.2.2. Product Portfolio

            21.6.2.3. key Financials

            21.6.2.4. Sales Footprint

            21.6.2.5. Strategy Overview

                21.6.2.5.1. Marketing Strategy

                21.6.2.5.2. Product Strategy

                21.6.2.5.3. Channel Strategy

        21.6.3. Atramat

            21.6.3.1. Overview

            21.6.3.2. Product Portfolio

            21.6.3.3. key Financials

            21.6.3.4. Sales Footprint

            21.6.3.5. Strategy Overview

                21.6.3.5.1. Marketing Strategy

                21.6.3.5.2. Product Strategy

                21.6.3.5.3. Channel Strategy

        21.6.4. Unilene

            21.6.4.1. Overview

            21.6.4.2. Product Portfolio

            21.6.4.3. key Financials

            21.6.4.4. Sales Footprint

            21.6.4.5. Strategy Overview

                21.6.4.5.1. Marketing Strategy

                21.6.4.5.2. Product Strategy

                21.6.4.5.3. Channel Strategy

        21.6.5. Hiossen

            21.6.5.1. Overview

            21.6.5.2. Product Portfolio

            21.6.5.3. key Financials

            21.6.5.4. Sales Footprint

            21.6.5.5. Strategy Overview

                21.6.5.5.1. Marketing Strategy

                21.6.5.5.2. Product Strategy

                21.6.5.5.3. Channel Strategy

    21.7. 21.4.12 Advanced MedTech Solutions Pvt. Ltd

            21.7.1.1. Overview

            21.7.1.2. Product Portfolio

            21.7.1.3. key Financials

            21.7.1.4. Sales Footprint

            21.7.1.5. Strategy Overview

                21.7.1.5.1. Marketing Strategy

                21.7.1.5.2. Product Strategy

                21.7.1.5.3. Channel Strategy

        21.7.2. Dolphin Sutures

            21.7.2.1. Overview

            21.7.2.2. Product Portfolio

            21.7.2.3. key Financials

            21.7.2.4. Sales Footprint

            21.7.2.5. Strategy Overview

                21.7.2.5.1. Marketing Strategy

                21.7.2.5.2. Product Strategy

                21.7.2.5.3. Channel Strategy

        21.7.3. Arthrex, Inc

            21.7.3.1. Overview

            21.7.3.2. Product Portfolio

            21.7.3.3. key Financials

            21.7.3.4. Sales Footprint

            21.7.3.5. Strategy Overview

                21.7.3.5.1. Marketing Strategy

                21.7.3.5.2. Product Strategy

                21.7.3.5.3. Channel Strategy

    21.8. 21.4.15 GMD Group

            21.8.1.1. Overview

            21.8.1.2. Product Portfolio

            21.8.1.3. key Financials

            21.8.1.4. Sales Footprint

            21.8.1.5. Strategy Overview

                21.8.1.5.1. Marketing Strategy

                21.8.1.5.2. Product Strategy

                21.8.1.5.3. Channel Strategy

    21.9. 21.4.16 Dynek Pvt Ltd

            21.9.1.1. Overview

            21.9.1.2. Product Portfolio

            21.9.1.3. key Financials

            21.9.1.4. Sales Footprint

            21.9.1.5. Strategy Overview

                21.9.1.5.1. Marketing Strategy

                21.9.1.5.2. Product Strategy

                21.9.1.5.3. Channel Strategy

    21.10. 21.4.17 Kono Seisakusho Co.,Ltd

            21.10.1.1. Overview

            21.10.1.2. Product Portfolio

            21.10.1.3. key Financials

            21.10.1.4. Sales Footprint

            21.10.1.5. Strategy Overview

                21.10.1.5.1. Marketing Strategy

                21.10.1.5.2. Product Strategy

                21.10.1.5.3. Channel Strategy

    21.11. 21.4.17 Olimp- Surgical Sutures

            21.11.1.1. Overview

            21.11.1.2. Product Portfolio

            21.11.1.3. key Financials

            21.11.1.4. Sales Footprint

            21.11.1.5. Strategy Overview

                21.11.1.5.1. Marketing Strategy

                21.11.1.5.2. Product Strategy

                21.11.1.5.3. Channel Strategy

    21.12. 21.4.18 Lotus Surgicals

            21.12.1.1. Overview

            21.12.1.2. Product Portfolio

            21.12.1.3. key Financials

            21.12.1.4. Sales Footprint

            21.12.1.5. Strategy Overview

                21.12.1.5.1. Marketing Strategy

                21.12.1.5.2. Product Strategy

                21.12.1.5.3. Channel Strategy

    21.13. 21.4.19 Unisur Lifecare Pvt Ltd.

            21.13.1.1. Overview

            21.13.1.2. Product Portfolio

            21.13.1.3. key Financials

            21.13.1.4. Sales Footprint

            21.13.1.5. Strategy Overview

                21.13.1.5.1. Marketing Strategy

                21.13.1.5.2. Product Strategy

                21.13.1.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Explore Healthcare Insights

View Reports

USA Knotless Surgical Sutures Market